Observational studyAnnals of hematology2026

Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.

Theerin Lanamtieng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.